Got PSMA SCAN Results-Now What? - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

Got PSMA SCAN Results-Now What?

Skippy3 profile image
14 Replies

In 2020 my PSA started to rocket up from a 4 at the beginning of the year to a 15.9 at year end. A biopsy was performed. On March 5, 2021 I received the results which indicated adenocarcinoma prostate cancer, with three Gleason score 8s and two 9s. On March 19 of that year a whole-body bone scan was performed and indicated “Abnormal uptake within the calvarium, spine, ribs, sacrum and iliacs compatible with metastatic disease”. A follow up CT scan with and without contrast showed “No compelling evidence of intrathoracic, intra-abdominal or intrapelvic metastatic disease or adenopathy”. By shear luck a relative of mine had a friend that was diagnosed with stage 4 Prostate Cancer. I talked to him and he highly recommended Dr Oliver Sartor at Tulane University. He’s been specializing in prostate cancer treatment for 30 years. My family friend, is still alive 17 years after diagnosis. Conveniently Dr Sartor’s office scheduled an appointment before any local oncologist, Mayo Clinic or MD Anderson. After meeting Dr Sartor I decided to cancel the other appointments and trust in him for the best treatment and advice.

On March 30 I visited Tulane. Bloodwork showed an increase in PSA level to 40. Dr Sartor was able to start me on 1000 mg of abiraterone acetate (Zytiga) and 5 mg of prednisone, that same day. April 9 a local oncologist gave me a 3 month dose of leoprolide acetate (Lupron). Soon thereafter there was a conflict between Dr Sartor and the local oncologist as he wanted me to start on a regime of denosumab (Xgeva). Dr Sartor said if anything, go with Prolia as it’s 60 mg of denosumab every 6 months vs the Xgeva regime which is 120 mg of denosumab every month. The conflict led my local oncologist to recommend I find another local doctor which would be more in tune with Dr Sartor. I whole heartedly agreed and did find a local oncologist that had worked with Dr Sartor in the past.

The good news is my PSA number dropped like a rock. Peeing problems greatly diminished. I could hold it and it actually came out when I wanted it to. The feeling that I have to pee right this second went away. I still wake up 3 or 4 times a night to pee but I can live with that. Pains in my hips and groin has also significantly lessened. I can live with where I am.

The local oncologist confirmed that we were following NCCN guidelines. Since it had been about 6 months since I started treatment, he recommended I get an Axumin or PSMA PET scan. I chose the later as it’s reported to be more accurate. In October of that year I received a PSMA PET piflufolastat F18 (Pylarify) scan using the latest GE PET scanning machine. I received a CD that shows areas of “uptake”. The follow-on report stated “There is abnormal uptake in the prostate gland diffusely….Maximum SUV value is 5.4 consistent with residual tumor.” And potentially worse “There is a focal area of mild increased uptake in the region of the clivus corresponding with a vague lytic and sclerotic lesion with an SUV value of 5.2”. The doctor also noted mild uptake on several spinal segments, T1, T2, T9, L3 and L4. To me this was a scary read. My follow-up question, is “now what”?

I had a subsequent visit with Dr Sartor’s office. Unfortunately, he had Covid at the time. Later by phone he told me that this is one frame of a movie. You need other pictures to determine if it’s getting better or worse. I asked when should I get another scan. He suggested I not get one until my PSA had increased to 1 or 2. My PSA dropped immediately after treatment started and has tended to be around 0.05 depending on who’s measuring it. Going from 0.05 to 1 or 2 scares me to death. By definition I would have transitioned to the castrate resistant version of this disease where the end is becoming more predictable. Months later I was able to quiz the radiation oncologist whose office set up the scan. He said his recommendation was to stay the course, no radiation or other treatment. I asked my local oncologist and he said the same thing. Not happy with that answer he set me up with another local radiation oncologist and he said the same thing. My follow on question is why do we even get these scans if no one is going to do anything about it?

I had to pay $6200 cash on the spot to get the scan in the first place. Trying to get reimbursed from my insurance company they needed a bill from the PET Scan place which was then jacked up to $8700. The insurance company paid $1700 and now the radiology provider wants me to pay an additional $4700. Something is screwed up here. The insurance company says the max I should owe is $250. You read that right.

For reference I’m included one of my PSMA PET scan images. I would like to add more but it looks like one is the limit. Tear glands and saliva glands light up as they produce PSMA. Liver, kidney and bladder light up as they are trying to remove the radionuclide from my system. Initially the machine initiates a CT scan. If you move the slightest bit the PSMA PET scan won’t line up perfectly. I probably moved my head. Tear and saliva glands are all over the place. Note that my PSA was 0.06 at the time of the scan.

This forum introduced me to Dr Kwon at Mayo Clinic, Rochester Minnesota, who put out three very intriguing youtube videos, youtube.com/watch?v=81iAzYV..., youtube.com/watch?v=Q2joD36..., and youtube.com/watch?v=IEToOBu.... One idea that I totally agree with is to stop talking about palliative therapy and start talking about curative therapy. After my PSMA PET scan I asked about hitting the hot spots with radiation. The local nurse practitioner said they only recommend radiation for palliative care. I’m thinking bring on the morphine. I’m not there yet physically or mentally. Mentally I’m thinking stay on the SOC+AAP curve and maybe after 5 years some better treatment will come along. Going back to the radiation idea, I have a prostate cancer friend that is on the SOC+AAP treatment but he has also received radiation in specific areas. Some of those areas were identified as painful. His PSA dropped after each treatment. Both of the radiation oncologists I talked to said they wouldn’t recommend radiation for me. I gather my cancer is too diffuse to hit and the collateral damage done wouldn’t be worth the effort.

I have a friend that had testicular cancer. It was hereditary. His father had it, and grandfather had it. His grandfather was given 6 months to live. At that time doctors were experimenting with using radiation to “cure” cancer. He agreed to be a guinea pig. The doctors stood him in front of the old time X-ray machines and blasted him for I don’t know how many treatments. He lived another 20 years. He died of a heart embolism due to the radiation. After his death an autopsy was performed and his guts showed significant damage from radiation. But think about it, 20 years of life and a quick death. At this point I would take that deal.

I see Dr Sartor in about a week to get my 6 month Eligard shot. He’s one of the leading experts in LU-177 treatment. To date he hasn’t brought up or suggested I think about that treatment. Do I have to, or should I wait until I’m castrate resistant before experimenting with other therapies? Dr Kwon suggests one consider “triplet” therapy, going after the cancer from different directions before it really has the upper hand. Sounds like a good idea but some information on this forum suggests “triplet” therapy caries more toxicity risk that traditional “doublet” therapy. One of this forums members, Rusland, has been on the Lu-177 + AC-225 therapy and his response is most impressive after he became castrate resistant. Another forum member “Unknown58” is high on, (no pun intended) very much likes, AMG-509.

So again my question is--- PSMA PET scan results received, now what? As I mentioned, I see Dr Sartor in about a week. I intend to quiz him again about:

•Is the PSMA PET scan I took of any use? I’m particularly concerned about clivus bone uptake.

•Should I stay the course until castrate resistant?

•Then do I do chemo, LU177, LU177+AC225, AMG-509 or something else?

As always your informed comments welcome.

Written by
Skippy3 profile image
Skippy3
To view profiles and participate in discussions please or .
Read more about...
14 Replies
Tall_Allen profile image
Tall_Allen

Don't take medical information from Internet videos. Dr Sartor is the best. Ask him about his Th-227-PSMA trial.

Skippy3 profile image
Skippy3 in reply to Tall_Allen

Will do

Brysonal profile image
Brysonal

Gosh Skippy3 I feel for you having heard similar re mets to the spine. Every time I read slides from the various conferences the specialists present at somebody says ‘ offer clinical trials to all’ . Not always easy to get the right one at the right time but great advise as ever from Tall Allen.

I went out of pocket for early Lu-177 ( had to travel too) but the HT/Abi/Chemo triplet was available from my London MO who is very standard of care so may be worth discussing early chemo too. I only had three early chemo due to starting with 3 Lu-177 ( very non standard) but it was not the big monster I had built it up to be. I was fully iced and kept all hair and nails and no neuropathy

I also had radiotherapy to the prostate as my RO took ‘stampede trial’ type scans that only showed 1 met ( PSMA showed loads) so was told I fitted the stampede trial criteria to benefit from radiotherapy to the primary.

Good Luck and keep us up to date.

tango65 profile image
tango65

I would consider a direct biopsy in areas identified by the PSMA PET/CT, to do IHC, histological and genetic studies. They could be info leading to therapies with PARP inhibitors (olaparib, rucaparib) or with checkpoint inhibitors such a Keytruda or other drugs in clinical trials.

Since the cancer has several areas expressing PSMA, you could consult abroad about treatment with LU 177 and/or Ac 225 (combo treatment), if financially possible.

Having an hormone sensitive cancer with a very low PSA makes very difficult or impossible to qualify for any clinical trial. Thorium trials are not recruiting and the trial for PC was for mCRPC.

Tulane has a clinical trial for castration sensitive PC

clinicaltrials.gov/ct2/show...

Seasid profile image
Seasid in reply to tango65

I think it is better to wait with the biopsy of the mets as the cancer could further change in the future. I think we should not deploy Olaparib at this stage when the ADT alone is doing its job, even if the biopsy sample would recommend Olaparib. If we attack the cancer with Olaparib early the cancer will move on after some time. In short we don't need a biopsy of the mets until a hormone therapy is working well. Another question is where would you biopsy if the PSA is as low as it is? Even a PSMA PET wouldn't find anything at this stage.

tango65 profile image
tango65 in reply to Seasid

He does not need any change in the treatment until there if evidence of radiological progression of the cancer. I was not proposing to use any particular treatment, just to do the studies to determine if the cancer have mutations which could make the cancer susceptible to treatment with specific drugs.

He said "Got PSMA SCAN Results-Now What?" I thought the PSMA PET/CT findings he mentioned in the post were recent, under the present treatment. I perhaps misunderstood the post.

Seasid profile image
Seasid in reply to tango65

Fair enough. Thanks for the explanation. István

Skippy3 profile image
Skippy3 in reply to tango65

Genealogical tests of germline and somatic mutations were done and there was nothing that stood out as something that could be used later on to customize treatment. I was not aware of the clinical trial that you mentioned. I was not asked to participate when I first visited Tulane. Seems like I would have fit relevant criteria at the time. Now I've had too many courses of abiraterone to be accepted.

tango65 profile image
tango65 in reply to Skippy3

You do not need to change treatment unless there is radiographic progression of the cancer.

The triple therapy mentioned by some posts as better than ADT plus abiraterone, applies only to de novo diagnosis (PEACE 1 trial) and it does not applies to your situation since you started the treatment last year. There is not evidence that adding chemo now will offer an advantage.

Seasid profile image
Seasid in reply to tango65

Maybe he could wait with the chemo until the hormone therapy fails? When it fails deploy chemotherapy and try Enzalutamide or even better Nubequa after 6 cycles of docetaxel? What do you think? When PSA 1 or 2 is reached have a PSMA PET scan to see where your cancer is now and try to successfully biopsy the mets if you can. After the chemo start Nubequa if you can and if it is recommended. You may want to have a STAMPEDE style nuclear medicine bone scan and CT in order to radiologically monitor the effectiveness of the therapy (maybe Nubequa or Enzalutamide). Of course the most important will be what his oncologist think as we don't really know all his results nor we can order anything. Maybe liquid biopsy but not with the intention to put him into some phase I clinical trials where the goal is to find out the toxicity of the new drug. I personally would wait with the liquid biopsy unlit there is a compelling reason to have one. What do you think tango65? What would you do about the therapy and the biopsy?

tango65 profile image
tango65 in reply to Seasid

When ADT plus abiraterone fails and there is radiographic (mCRPC) or symptomatic progression of the cancer, the SOC is chemotherapy and Provenge along with Denosumab if there are bone metastases. Eventually they could try enzalutamide or other of the new anti androgens, Xofigo, Lu 177 PSMA, olaparib, rucaparib, Keytruda etc.

Biopsy to study the genome of the cancer is very important to see if the cancer could be susceptible to targeted therapies. Liquid biopsy has a low yield if the PSA is below 10 and there are few bone metastases. Direct biopsy if the mets are accesible can be done at any time.

I agree with you about phase I clinical trials. I have been treated in clinical trials but they were phase II. The doses were known , there were preliminary results published and I was sure I will get the treatment.

Djangler profile image
Djangler

As Brysonal said, you may want to consider adding Docetaxol. If you're in good health overall, you should tolerate it well. I had very limited side effects. Talk to your oncologist about the recent PEACE-1 trial. In that study, the people who benefitted most had higher volume of bone mets than you but it was good for the entire population.

j-o-h-n profile image
j-o-h-n

Greetings Skippy 3,

I may have missed it or you may Skipped it.......Age? Location? (city/state).....

Thank you and keep posting...

Good Luck, Good Health and Good Humor.

j-o-h-n Tuesday 07/05/2022 6:30 PM DST

Skippy3 profile image
Skippy3 in reply to j-o-h-n

Just turned 67 and live in Stuart, Florida. Thanks all for suggestions so far. Stay tuned.

You may also like...

PSMA Pet Scan results

the results from PSMA Pet Scan: “Highly PSMA positive tumor in the left prostate gland, increased...

PSMA Pet Scan results

with prostate cancer with 1 lesion Gleason 7 (4+3). Have had MRI, biopsy and just completed PSMA...

PSMA PET scan results

the bottom of my sternum and my prostate is showing new mild uptake. The good news: All of the...

Latest PSMA PET Scan Results - What to do next?

base. The prostate now demonstrates significantly decreased PSMA uptake, as compared to prior...

Axumin scan results...now onto PSMA scan

more sensitive scan but I was surprised by their treatment recommendation after the scan is...